Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 AUD | -4.01% |
|
+0.35% | -34.77% |
05-01 | Nanosonics Submits De Novo Application to US FDA for CORIS Cleaning Technology | MT |
03-15 | Nanosonics Chief Technology Officer to Retire | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- With an expected P/E ratio at 105.73 and 69.28 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 4.69 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-34.77% | 604M | B+ | ||
+4.18% | 211B | B | ||
+8.00% | 185B | B- | ||
+31.86% | 158B | B- | ||
+2.70% | 64.32B | A- | ||
+21.14% | 55.66B | B+ | ||
+0.11% | 48.41B | B+ | ||
-6.76% | 37.82B | A | ||
+0.78% | 35.57B | - | ||
+11.28% | 28.12B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NAN Stock
- Ratings Nanosonics Limited